The Capital, 1802/1901 18th Floor, Plot No. C - 70, G Block Bandra Kurla Complex Bandra (East) Mumbai MH India
Rajendra Ambalal Shah (Chairman),Sridhar Subramaniam (Chief Executive Officer)
UPDATE 1-Pfizer considers $100 bln bid for AstraZeneca - report
(Adds no comment from Pfizer and AstraZeneca, context)LONDON, April 20 (Reuters) - U.S. pharmaceutical giantPfizer has approached British rival AstraZeneca to propose a 60 billion pound ($101 billion)
Pfizer, Merck KGaA score a landmark FDA OK for checkpoint contender avelumab
Merck KGaA and Pfizer have done it. The biopharma partners came away with their first FDA approval of the checkpoint inhibitor avelumab, making it the fourth drug in this category to make it to the...
About that AstraZeneca bid defence … | FT Alphaville
The nationalistic bluster around AstraPfizica remains blustery. Here, for example, is London Mayor Boris Johnson: It would be very important to establish that Pfizer is genuinely committed to R&D in this country. I believe in principle that we should have an open system of markets in this country, but when I look at something like AstraZeneca and I look at an organization of that scale, of its relative importance to the UK economy, the sheer percentage of its money that goes into R&D, I think it is of great importance to Britain. With that in mind, it's worth taking a closer look at the experimental drug pipeline AstraZeneca has highlighted in its defence statement. These are the drugs that management expects to deliver an incremental $19bn of sales from 2017 to 2023, equivalent to 10 per cent revenue growth per annum:
Why an Ex-Google Coder Makes Twice as Much Freelancing
With a talent war raging, companies from Airbnb to Pfizer are paying top dollar for the services of independent programmers
Pfizer, BioNTech COVID-19 vaccine trial successful
The Pfizer and BiNTech COVID-19 vaccine showed positive results as it created antibodies against the SARS-CoV-2 virus, a paper on MedRXiv revealed on Wednesday. The study also showed that patients ...
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billio...
UK and US step up pressure on Pfizer over bid for AstraZeneca - FT.com
Pfizer’s £63bn takeover approach for AstraZeneca was facing mounting political scrutiny on two fronts on Friday as senior US and UK politicians intensified their questions over the proposed deal. Nick Clegg, UK deputy prime minister, said Pfizer
Pfizer Makes AstraZeneca Takeover Case to Parliament - Bloomberg
Pfizer Makes AstraZeneca Takeover Case to Parliament
How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race
German biotech BioNTech SE worked on cancer treatments, and was developing an influenza vaccine with Pfizer Inc., when its founder, Ugur Sahin, led the company’s pivot to the coronavirus in January.